Matches in DBpedia 2016-04 for { <http://doi.org/10.1016/j.jaac.2012.08.015> ?p ?o }
Showing triples 1 to 16 of
16
with 100 triples per page.
- j.jaac.2012.08.015 accessdate "2014-06-30".
- j.jaac.2012.08.015 author "Scassellati C, Bonvicini C, Faraone SV, Gennarelli M".
- j.jaac.2012.08.015 date "October 2012".
- j.jaac.2012.08.015 doi "10.1016/j.jaac.2012.08.015".
- j.jaac.2012.08.015 isCitedBy Phenethylamine.
- j.jaac.2012.08.015 issue "10".
- j.jaac.2012.08.015 journal "J. Am. Acad. Child Adolesc. Psychiatry".
- j.jaac.2012.08.015 last2 "Bonvicini".
- j.jaac.2012.08.015 last3 "Faraone".
- j.jaac.2012.08.015 last4 "Gennarelli".
- j.jaac.2012.08.015 pages "1003–1019.e20".
- j.jaac.2012.08.015 pmid "23021477".
- j.jaac.2012.08.015 quote "Although we did not find a sufficient number of studies suitable for a meta-analysis of PEA and ADHD, three studies20,57,58 confirmed that urinary levels of PEA were significantly lower in patients with ADHD compared with controls. ... Administration of D-amphetamine and methylphenidate resulted in a markedly increased urinary excretion of PEA,20,60 suggesting that ADHD treatments normalize PEA levels. ... Similarly, urinary biogenic trace amine PEA levels could be a biomarker for the diagnosis of ADHD,20,57,58 for treatment efficacy,20,60 and associated with symptoms of inattentivenesss.59 ... With regard to zinc supplementation, a placebo controlled trial reported that doses up to 30 mg/day of zinc were safe for at least 8 weeks, but the clinical effect was equivocal except for the finding of a 37% reduction in amphetamine optimal dose with 30 mg per day of zinc.110".
- j.jaac.2012.08.015 title "Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses".
- j.jaac.2012.08.015 url 9fcfd50751edb5a22a.pdf?origin=publication_detail.
- j.jaac.2012.08.015 volume "51".